Chicago, IL - 2016 ASCO Annual Meeting - Edmund Moon presenting Engineered T-Cells for the Treatment of Lung and Other Thoracic Cancers during Immunotherapy: Beyond Anti-PD-1 and Anti-PDL1 Therapies Education Session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Tuesday, June 7, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Todd Buchanan 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org
Chicago, IL - 2016 ASCO Annual Meeting - Speaker: Peter Schmid during Tumor Biology Titled:Association of PD-L2 expression in human tumors with atezolizumab activity during Oral Session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Tuesday, June 7, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Todd Buchanan 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org
